בנגיי קרם לא שומני להקלת כאב ישראל - עברית - Ministry of Health

בנגיי קרם לא שומני להקלת כאב

j-c health care ltd - menthol; methyl salicylate - קרם - methyl salicylate 15 %w/w; menthol 10 %w/w - various - various - this medicine is indicated for the temporary relief of minor aches and pains of muscles and joints, such as simple backache, lumbago, arthritis, strains, bruises and sprains.

surgical instruments delievery system ישראל - עברית - Ministry of Health

surgical instruments delievery system

"אבנט ציוד רפואי בע""מ" - אחות - מארזים לעיקור

Penfine universal click pen needle and accesories for various pen systems ישראל - עברית - Ministry of Health

penfine universal click pen needle and accesories for various pen systems

גפן מדיקל בע"מ - כלל האוכלוסיה - אנדוקרינולוגיה - מחטים ואביזרים נלווים להזרקה תת עורית

ANGIODYNAMICS products acc to list ישראל - עברית - Ministry of Health

angiodynamics products acc to list

אלסמד מערכות רפואיות בע"מ - מומחה - irreversible electroporation (ire) is a non-thermal, ablation technology designed for precise and effective surgical ablation of soft tissue

Rehabilitation products,hospital beds, mattress, levers, ישראל - עברית - Ministry of Health

rehabilitation products,hospital beds, mattress, levers,

חגי מכשור רפואי וסיעודי בע"מ - כלל האוכלוסיה - מכשור עזר לנכים, מיטות אשפוז, מזרנים

Trevo Endovascular Retriever ישראל - עברית - Ministry of Health

trevo endovascular retriever

אינטרומדיקס בע"מ - רופא - נוירו-רגיולוג פולשני

פרלסיט ישראל - עברית - Ministry of Health

פרלסיט

sanofi - aventis israel ltd - ferrous gluconate as iron iii sodium ferric glugonate compl. 62.5 mg / 5 ml - solution for injection - various combinations - severe iron deficiency states only when oral administration has been found impossible in cases of gastrointestinal malabsorption which rules out oral iron therapy patients treated by dialysis getting erythropoietin.

בינוקריט 1000 יחבל 0.5 מל ישראל - עברית - Ministry of Health

בינוקריט 1000 יחבל 0.5 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

בינוקריט 2000 יחבל 1 מל ישראל - עברית - Ministry of Health

בינוקריט 2000 יחבל 1 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob